| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Health Care (XLV) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Health Care sector is very positive (overall 2.3, positive 2.8, negative -0.5) on 20250930. The forces of Price Level (2), Option Speculation (1.5), Sentiment towards Fundamentals (1.5), Sector Price Trend (0.3), Broad Market Trend (0.2), and Valuation Sentiment (-1) will drive up the price. The forces of and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (2.8). The extreme bullish overall sentiment (2.3) may signal the top of this uptrend. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XLV trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2% | 1.1% | 139.2 | 92 | 2.43% | 0.22% | 1.2 | 0.3 | 1.5 | 5.6 |
| 2025-09-29 | 1% | 1% | 135.9 | 23 | 0.28% | -0.07% | 0.8 | -0.2 | 1.2 | 1.3 |
| 2025-09-28 | 1% | 1.4% | 0.3 | -0.3 | 0.6 | 7 | ||||
| 2025-09-27 | 0% | 1.9% | 0.2 | -0.3 | 0.5 | 0 | ||||
| 2025-09-26 | 1% | 2% | 135.52 | 11 | 1.01% | -0.22% | -0.1 | -0.3 | -0.1 | 2 |
| 2025-09-25 | 2% | 1.9% | 134.16 | -26 | -1.65% | -0.44% | 0.4 | -0.4 | 0.1 | -0.3 |
| 2025-09-24 | 1% | 1.6% | 136.41 | 17 | -0.39% | -0.07% | 0.6 | -0.2 | 0.5 | 2 |
| 2025-09-23 | 1% | 1.4% | 136.95 | 34 | 0.25% | -0.07% | 0.5 | -0.1 | 0.6 | 2.6 |
| 2025-09-22 | 4% | 1.3% | 136.62 | 24 | -0.47% | -0.07% | 0.7 | -0.2 | 0.6 | 4.1 |
| 2025-09-21 | 4% | 0.7% | 0.8 | -0.2 | 0.8 | 5.4 | ||||
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (7) Thermo Fisher Scientific Shares Up 3.3% After Power Inflow Signal Thermo Fisher Scientific shares flashed a power inflow signal at a price of $464.71, after which TMO rose to an intraday high, representing a 3.3% gain. (https://www.benzinga.com/) Tue. Sep 30, 2025 | |
| 2 (7) Pfizer Shares Are Trading Higher Tuesday: What's Going On? Pfizer, Inc. (NYSE:PFE) shares are trading higher on Tuesday after The Washington Post reported that President Donald Trump will announce a drug-pricing deal with the company. (https://www.benzinga.com/) Tue. Sep 30, 2025 | |
| 3 (8) Danaher Corp. stock outperforms competitors on strong trading day Shares of Danaher Corp. DHR rallied 6.56% to $198.26 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.41% to 6,688.46 and the Dow Jones Industrial Average DJIA rising 0.18% to 46,397.89. This was the stock's third consecutive day of gains. (https://www.marketwatch.com/) Tue. Sep 30, 2025 | |
| 4 (7) Charles River Laboratories International Inc. stock outperforms competitors on strong trading day Shares of Charles River Laboratories International Inc. CRL rose 6.44% to $156.46 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.41% to 6,688.46 and the Dow Jones Industrial Average DJIA rising 0.18% to 46,397.89. Charles River Laboratories International Inc. closed 31.98% below its 52-week high of $230.02, which the company achieved on November 6th. (https://www.marketwatch.com/) Tue. Sep 30, 2025 | |
| 5 (7) Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market Shares of Thermo Fisher Scientific Inc. TMO rallied 4.97% to $485.02 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.41% to 6,688.46 and the Dow Jones Industrial Average DJIA rising 0.18% to 46,397.89. Thermo Fisher Scientific Inc. closed 21.77% below its 52-week high of $620.00, which the company reached on October 1st. (https://www.marketwatch.com/) Tue. Sep 30, 2025 | |
| 6 (2) Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown Thermo Fisher sells four-part dollar bonds as U.S. investment-grade issuance tops $200 billion, with yields near historic lows and spreads tight. (https://www.benzinga.com/) Tue. Sep 30, 2025 | |
| 7 (-4) Walmsley’s GSK Exit Leaves FTSE 100 Female CEO Tally Stagnating Emma Walmsley’s departure as chief executive officer of GSK Plc ends a near nine-year tenure at the British drugmaker. It also means the UK is losing another high-profile female business leader. (https://www.bloomberg.com/) Tue. Sep 30, 2025 | |
| 8 (8) From Senior Living to Social Media, Massive Funding Rounds Signal AI's Mainstream Breakthrough AI startups attract over $1.5B in recent funding rounds, signaling rapid growth across infrastructure, healthcare, and enterprise sectors. (https://www.benzinga.com/) Tue. Sep 30, 2025 | |
| 9 (8) Bernstein sees ’a strong buying opportunity’ in this U.S. medical stock Bernstein sees ’a strong buying opportunity’ in this U.S. medical stock (https://www.investing.com/) Tue. Sep 30, 2025 | |
| 10 (0) GSK's Walmsley to step down early as insider Luke Miels named next CEO GSK's CEO Emma Walmsley will step down in December and be replaced by insider Luke Miels, the British drugmaker said on Monday. (https://www.cnbc.com/) Mon. Sep 29, 2025 | |
| 11 (4) CoreWeave, AstraZeneca, GSK, BYD, Tesla: Trending Stocks Stocks to watch this morning include CoreWeave (CRWV), the NVIDIA (NVDA)-backed AI cloud scaler, which is rising after some big swings in recent weeks. In the pharmaceutical sector, AstraZeneca (AZN) gains as it announces plans to list in New York, while GSK (GSK) and UCB SA (UCB.BR) are up on appointing a new CEO and positive trial results, respectively. And it's a high-stakes moment for Tesla (TSLA), BYD (1211.HK) and other makers of electric vehicles, amid a global slowdown and as a $7,500 tax credit comes to an end in the US. For more live coverage of markets watch the full episode of Market Sunrise and head to Yahoo Finance. (https://finance.yahoo.com/) Mon. Sep 29, 2025 | |
| 12 (8) Cannabis stocks surge after Trump endorses cannabidiol for senior healthcare (Reuters) -Shares of pot companies climbed in premarket trading on Monday after U.S. President Donald Trump advocated the potential benefits from the use of cannabidiol in senior healthcare in a social media post. Trump had said last month his administration was looking to reclassify marijuana, which could also result in potentially easing criminal penalties around its use. Hemp-derived cannabidiol (CBD) could "revolutionize senior healthcare" by helping reduce disease progression and was shown as an alternative to prescription drugs, he said in a post on Truth Social on Sunday. (https://finance.yahoo.com/) Mon. Sep 29, 2025 | |
| 13 (-7) Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, as it set the most pessimistic target price forecast of any Wall Street bank on the Danish drugmaker. (https://www.marketwatch.com/) Mon. Sep 29, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA